ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print June 18, 2009, 10.1183/09031936.00055509
Eur Respir J 2009; 34:1086-1092
Copyright ©ERS Journals Ltd 2009
doi: 10.1183/09031936.00055509

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/5/1086    most recent
09031936.00055509v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Google Scholar
Right arrow Articles by Murray, M. P.
Right arrow Articles by Hill, A. T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murray, M. P.
Right arrow Articles by Hill, A. T.

A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis

M. P. Murray1, J. L. Pentland2 and A. T. Hill1

Depts of 1 Respiratory Medicine, and 2 Physiotherapy (Respiratory Medicine), Royal Infirmary of Edinburgh, Edinburgh, UK.

CORRESPONDENCE: M. P. Murray, Dept of Respiratory Medicine, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SA, UK. E-mail: maevemurray{at}hotmail.com

Keywords: Bronchiectasis, physiotherapy

Received: April 3, 2009
Accepted June 3, 2009

Regular chest physiotherapy is advocated in non-cystic fibrosis bronchiectasis despite little evidence supporting its routine use. This study aimed to establish the efficacy of regular chest physiotherapy in non-cystic fibrosis bronchiectasis compared with no regular chest physiotherapy.

20 patients not practising regular chest physiotherapy were enrolled in a randomised crossover trial of 3 months of twice daily chest physiotherapy using an oscillatory positive expiratory pressure device compared with 3 months of no chest physiotherapy. The primary end-point was the Leicester Cough Questionnaire (LCQ). Additional outcomes included 24-h sputum volume, forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), forced expiratory flow at 25–75% of FVC (FEF25–75%), maximum inspiratory pressure (MIP), maximum expiratory pressure (MEP), exercise capacity, sputum microbiology and St George's Respiratory Questionnaire (SGRQ). The treatment effect was estimated using the differences of the pairs of observations from each patient.

There was a significant improvement in all domains and total LCQ score with regular chest physiotherapy (median (interquartile range) total score improvement 1.3 (-0.17–3.25) units; p = 0.002). 24-h sputum volume increased significantly with regular chest physiotherapy (2 (0–6) mL; p = 0.02), as did exercise capacity (40 (15–80) m; p = 0.001) and SGRQ total score (7.77 (-0.99–14.5) unit improvement; p = 0.004). No significant differences were seen in sputum bacteriology, FEV1, FVC, FEF25–75%, MIP or MEP.

Regular chest physiotherapy in non-cystic fibrosis bronchiectasis has small, but significant benefits.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the European Respiratory Society.